KH-3

• CAT Number: I042938
• CAS Number: 1215115-03-9
• Molecular Formula: C21H22N2O4S2
• Molecular Weight: 430.54
• Purity: ≥95%
• Synonyms: (E)-3-[5-[(4-tert-butylphenyl)sulfonylamino]-1-benzothiophen-2-yl]-N-hydroxyprop-2-enamide
• InChI: InChI=1S/C21H22N2O4S2/c1-21(2,3)15-4-8-18(9-5-15)29(26,27)23-16-6-10-19-14(12-16)13-17(28-19)7-11-20(24)22-25/h4-13,23,25H,1-3H3,(H,22,24)/b11-7+
• InChIKey: RIYPLPNXICDUCS-YRNVUSSQSA-N
• SMILES: CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=CC3=C(C=C2)SC(=C3)/C=C/C(=O)NO

KH-3（Cat No.:I042938）is a small molecule compound that has shown potential as an inhibitor of specific enzymes involved in cell signaling and tumor progression. It is particularly studied for its effects on pathways that regulate cell proliferation, survival, and apoptosis in cancer cells. KH-3 has demonstrated promise in preclinical models for targeting cancers, especially those resistant to traditional therapies. By disrupting key molecular interactions within cancer cells, KH-3 may enhance the effectiveness of existing treatments. Ongoing research is focused on its safety, pharmacokinetics, and potential therapeutic applications in oncology.